Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Ambrisentan plus Spironolactone
(D00443)		[2] Ambrisentan,
Spironolactone		[2] Spironolactone (D00443),
Ambrisentan 💬 		[2] EDNRA,
NR3C2 💬 		[8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
2Ramipril Tritace®, Carvedilol Carvid®,and Spironolactone Aldactone®
(D00443)		[3] Carvedilol,
Ramipril,
Spironolactone		[4] Carvedilol ,
Ramipril ,
Spironolactone (D00443),
Carvedilol phosphate 💬 		[7] ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬 		[21] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 57 💬
3Spironolactone
(D00443)		[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[12] 46, 57, 58, 67, 86, 113, 210, 214, 218, 222, 223, 225 💬
4Spironolactone (drug)
(D00443)		[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 210 💬
5Spironolactone and conivaptan
(D00443)		[2] Conivaptan,
Spironolactone		[3] Spironolactone (D00443),
Conivaptan hydrochloride ,
Conivaptan 💬 		[3] AVPR1A,
AVPR2,
NR3C2 💬 		[7] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 86 💬
6Spironolactone captopril carvedilol
(D00443)		[3] Captopril,
Carvedilol,
Spironolactone		[4] Captopril ,
Carvedilol ,
Spironolactone (D00443),
Carvedilol phosphate 💬 		[7] ACE,
ADRA1A,
ADRA1B,
ADRA1D,
ADRB1,
ADRB2,
NR3C2 💬 		[21] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Chemical carcinogenesis - receptor activation, Coronavirus disease, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
7Spironolactone Mylan 25 mg comprimé pelliculé sécable
(D00443)		[1] Spironolactone[1] Spironolactone (D00443) 💬 [1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 46 💬
8Spironolactone or Finerenone
(D00443)		[2] Finerenone,
Spironolactone		[2] Spironolactone (D00443),
Finerenone 💬 		[1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 218 💬
9Treatment with Dapagliflozin followed by Spironolactone followed by their combination
(D00443)		[2] Dapagliflozin,
Spironolactone		[2] Spironolactone (D00443),
Dapagliflozin 💬 		[1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 218 💬
10Treatment with Spironolactone followed by Dapagliflozin followed by their combination
(D00443)		[2] Dapagliflozin,
Spironolactone		[2] Spironolactone (D00443),
Dapagliflozin 💬 		[1] NR3C2 💬 [1] Aldosterone-regulated sodium reabsorption 💬[1] 218 💬